Are you Dr. Rosenfeld?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 55 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
222 S Woods Mill Rd
Suite 610N
Chesterfield, MO 63017Phone+1 314-453-9300- Is this information wrong?
Summary
- Dr. William Rosenfeld, MD is a board certified neurologist in Chesterfield, Missouri. He is currently licensed to practice medicine in Missouri, Minnesota, and Florida. He is affiliated with Cox Medical Centers.
Education & Training
University of Miami/Jackson Health SystemResidency, Neurology, 1980 - 1983- University of Miami/Jackson Health SystemInternship, Internal Medicine, 1979 - 1980
Texas Tech University Health Sciences Center School of MedicineClass of 1979
Certifications & Licensure
MO State Medical License 1987 - 2025
MN State Medical License 1984 - 1987
FL State Medical License 1980 - 1985- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2011-2013
Clinical Trials
- Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy Start of enrollment: 2010 Jun 01
- Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures Start of enrollment: 2011 Jul 06
- Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension Start of enrollment: 2013 Oct 01
Publications & Presentations
PubMed
- 15 citationsLong-term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development programJosemir W. Sander, William E. Rosenfeld, Jonathan J. Halford, Bernhard J. Steinhoff, Victor Biton, Manuel Toledo> ;Epilepsia. 2021 Nov 23
- 22 citationsPost hoc analysis of a phase 3, multicenter, open-label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant an...William E. Rosenfeld, Bassel Abou-Khalil, Sami Aboumatar, Perminder Bhatia, Victor Biton, Gregory L. Krauss, Michael R. Sperling, David G. Vossler, Pavel Klein, Robert...> ;Epilepsia. 2021 Oct 11
- 22 citationsEfficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open-label study.Michael R. Sperling, Bassel Abou-Khalil, Sami Aboumatar, Perminder Bhatia, Victor Biton, Pavel Klein, Gregory L. Krauss, David G. Vossler, Robert T. Wechsler, Louis Fe...> ;Epilepsia. 2021 Oct 11
- Join now to see all
Press Mentions
Latest XCOPRI® (Cenobamate Tablets) CV Post-Hoc Analysis Presented at the 75th American Academy of Neurology Annual MeetingApril 17th, 2023- Epilepsia Publishes Two Post-Hoc Analyses from Long-Term Study of XCOPRI® (Cenobamate Tablets) CVOctober 12th, 2021
- Epilepsia Publishes Two Post-Hoc Analyses from Long-Term Study of XCOPRI® (Cenobamate Tablets) CVOctober 12th, 2021
- Join now to see all
Hospital Affiliations
Cox Medical CentersSpringfield, Missouri
